Evidence map›Paper›PMID 37812061›Full record

ArticleNeuropathology and applied neurobiology2023

A high-throughput single-cell RNA expression profiling method identifies human pericyte markers.

Andras Sziraki, Yu Zhong, Allison M Neltner, Dana M Niedowicz, Colin B Rogers, Donna M Wilcock, Geetika Nehra, Janna H Neltner, Rebecca R Smith, Anika M Hartz and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropathology and applied neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Pericytes in tissue fibrosis.American journal of physiology. Cell physiology · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Andras SzirakiLaboratory of Single Cell Genomics and Population Dynamics, The Rockefeller University, New York, New York, USA.
Yu ZhongSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Allison M NeltnerSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Dana M NiedowiczSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Colin B RogersSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Donna M WilcockSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Geetika NehraDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.
Janna H NeltnerDepartment of Pathology and Laboratory Science, University of Kentucky, Lexington, Kentucky, USA.
Rebecca R SmithDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.
Anika M HartzSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Junyue CaoLaboratory of Single Cell Genomics and Population Dynamics, The Rockefeller University, New York, New York, USA.
Peter T NelsonSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.ORCID 0000-0002-6161-1265
University of Kentucky · USRockefeller University · US

Funding

Strategies for Targeting Astrocyte Reactivity in Alzheimer's Disease and Related DementiasP01AG078116 · NIA · UNIVERSITY OF KENTUCKY · PI PETER T. NELSON · 2022 to 2026
$25.0M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Federated digital pathology platform for AD/ADRD research and diagnosticsU24NS133945 · NINDS · UNIVERSITY OF KENTUCKY · PI BUMGARDNER, CODY, FLANAGAN, MARGARET E · 2023 to 2025
$4.9M
Novel Therapeutic Strategies to Resolve Neurovascular Inflammation and Repair Blood-Brain Barrier Dysfunction in EpilepsyR01NS079507 · NINDS · UNIVERSITY OF MINNESOTA · PI BAUER, BJOERN · 2012 to 2025
$4.5M
Development of novel genomic approaches for profiling cellular temporal-spatial dynamics of neurogenesis in Aging and Alzheimer's diseaseR01AG076932 · NIA · ROCKEFELLER UNIVERSITY · PI Junyue Cao · 2022 to 2026
$4.0M
Blood-Brain Barrier Repair in Alzheimer’s Disease with EpilepsyR01AG075583 · NIA · UNIVERSITY OF KENTUCKY · PI Bjoern Bauer, Anika M.S. Hartz · 2022 to 2026
$3.6M
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS)R01AG061111 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2019 to 2025
$3.6M
Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classificationRF1NS118584 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CYKOWSKI, MATTHEW DANIEL, NELSON, PETER T. · 2020 to 2020
$3.2M
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s DiseaseR01NS133250 · NINDS · UNIVERSITY OF KENTUCKY · PI Anika M.S. Hartz · 2023 to 2026
$2.9M
Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology DementiaRF1AG082339 · NIA · UNIVERSITY OF KENTUCKY · PI FARDO, DAVID WILLIAM, NELSON, PETER T. · 2023 to 2023
$1.7M
nvestigating the role of neuroinflammation in Limbic-predominant age related TDP43 encephalopathyK08AG065463 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FLANAGAN, MARGARET E · 2020 to 2024
$816k
NIA NIH HHS K08 AG065463NIA NIH HHS P01 AG078116NIA NIH HHS P30 AG072946NIA NIH HHS R01 AG061111NIA NIH HHS R01 AG075583NIA NIH HHS R01 AG076932NIA NIH HHS RF1 AG082339NIH HHS P30 AG072946NIH HHS R01 AG061111NIH HHS R01 AG076932NIH HHS R01AG076932NIH HHS RF1 NS118584NINDS NIH HHS R01 NS079507NINDS NIH HHS R01 NS133250NINDS NIH HHS RF1 NS118584NINDS NIH HHS U24 NS133945
6 · The paper itself

Abstract

aimsWe sought to identify and optimise a universally available histological marker for pericytes in the human brain. Such a marker could be a useful tool for researchers. Further, identifying a gene expressed relatively specifically in human pericytes could provide new insights into the biological functions of this fascinating cell type.

methodsWe analysed single-cell RNA expression profiles derived from different human and mouse brain regions using a high-throughput and low-cost single-cell transcriptome sequencing method called EasySci. Through this analysis, we were able to identify specific gene markers for pericytes, some of which had not been previously characterised. We then used commercially (and therefore universally) available antibodies to immunolabel the pericyte-specific gene products in formalin-fixed paraffin-embedded (FFPE) human brains and also performed immunoblots to determine whether appropriately sized proteins were recognised.

resultsIn the EasySci data sets, highly pericyte-enriched expression was notable for SLC6A12 and SLC19A1. Antibodies against these proteins recognised bands of approximately the correct size in immunoblots of human brain extracts. Following optimisation of the immunohistochemical technique, staining for both antibodies was strongly positive in small blood vessels and was far more effective than a PDGFRB antibody at staining pericyte-like cells in FFPE human brain sections. In an exploratory sample of other human organs (kidney, lung, liver, muscle), immunohistochemistry did not show the same pericyte-like pattern of staining.

conclusionsThe SLC6A12 antibody was well suited for labelling pericytes in human FFPE brain sections, based on the combined results of single-cell RNA-seq analyses, immunoblots and immunohistochemical studies.

Indexed as

PericytesRNAAnimalsBrainHumansImmunohistochemistryMiceReceptor, Platelet-Derived Growth Factor betaReceptor, Platelet-Derived Growth Factor betaRNABBBblood-brain barriercapillariesfolateGABAneurovascularSMCVCID

Identifiers

PMID37812061
PMCPMC10842535
OpenAlexW4387440113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.